SCHEMBL7317413

SCHEMBL7317413

OC1(c2ccc(F)cc2)c2ccccc2Oc2ccccc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM3 P20309 1/20 0.42
SCN9A Q15858 1/20 0.36
PDK2 Q15119 3/20 0.34
CCR1 P32246 1/20 0.33
ALOX5 P09917 1/20 0.33
OPRM1 P35372 1/20 0.33
OPRD1 P41143 1/20 0.33
OPRK1 P41145 1/20 0.33
OPRL1 P41146 1/20 0.33
P2RX1 P51575 1/20 0.33
P2RX3 P56373 1/20 0.33
P2RX4 Q99571 1/20 0.33
P2RX7 Q99572 1/20 0.33
HTT P42858 1/20 0.32
ATM Q13315 1/20 0.32
KIF11 P52732 1/20 0.32
BCHE P06276 1/20 0.32
STK17B O94768 1/20 0.32
MAOA P21397 1/20 0.31
MAOB P27338 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22048471 0.85 CHRM3 (0.44) CHRM3PDK2CCR1ALOX5P2RX1
SCHEMBL29722 0.84 CHRM3 (0.46) CHRM3SCN9ACCR1ALOX5P2RX1
SCHEMBL7322612 0.81 CHRM3 (0.45) CHRM3PDK2CCR1ALOX5OPRM1
SCHEMBL9700918 0.80 CHRM3 (0.41) CHRM3PDK2CCR1ALOX5P2RX1
SCHEMBL22048472 0.79 CHRM3 (0.40) CHRM3CCR1ALOX5P2RX1P2RX3
SCHEMBL7313184 0.79 PDK2 (0.49) PDK2OPRK1KIF11
SCHEMBL21645761 0.77 GAA (0.49) CHRM3PDK2ALOX5P2RX4
SCHEMBL30825751 0.77 CHRM3 (0.46) CHRM3SCN9APDK2OPRM1OPRD1
SCHEMBL5583991 0.77 CHRM3 (0.46) CHRM3SCN9APDK2OPRM1OPRD1
SCHEMBL22169938 0.73 KDM4E (0.44) CHRM3CCR1P2RX1P2RX3P2RX4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6162824-A NERVOUS SYSTEM DISORDERS; PSYCHOLOGICAL DISORDERS ALLELIX NEUROSCIENCE INC. 2000-12-19 US disclosed
WO-1999041227-A1 TRICYCLIC COMPOUNDS AS GLYCINE TRANSPORT INHIBITORS ALLELIX NEUROSCIENCE, INC. (US) 1999-08-19 WO disclosed